Table 1

A shift towards clinical target in asthma control (MID): impact on asthma control, cost savings and gains in health utility (annual estimates per patient)

Possible shifts
(current to target scenario)
ACTCosts for the healthcare providerUtility score
Current scenario (ACT)Target scenario
(ACT)
Gain in asthma control (fixed, MID)Annual saving (2015 euros, per patient)Gain in health utility
(years in full health saved)
1 RED to RED
Embedded Image
5–108–133NANA
2 RED to YELLOW
Embedded Image
11–1414–173−1857 (95% CI −2414 to −1393)0.09 (95% CI 0.088 to 0.092)
3 YELLOW to YELLOW
Embedded Image
15–1618–193NANA
4 YELLOW to GREEN
Embedded Image
18–1920–213−2333 (95% CI −3033 to −1750)0.29 (95% CI 0.28 to 0.30)
5 GREEN to GREEN
Embedded Image
20–21≥233NANA
  • Possible shifts:a shift in care landscape was considered towards a target scenario where a patient with asthma experienced a clinically significant change in ACT score equal to the MID of 3 points in ACT score.

  • ACT, Asthma Control Test; MID, minimally important difference; NA (not associated), no change in outcome was captured.